EDGAR Filing Documents for 0001193125-12-067417

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-067417

Filing Date

2012-02-17

Accepted

2012-02-17 16:05:09

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d300203d20f.htm	20-F	2651995
2	SUBSIDIARIES OF THE REGISTRANT	d300203dex8.htm	EX-8	14465
3	CONSENT OF KESSELMAN & KESSELMAN	d300203dex10.htm	EX-10	2779
4	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	d300203dex12i.htm	EX-12.(I)	9621
5	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	d300203dex12ii.htm	EX-12.(II)	9526
6	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	d300203dex13.htm	EX-13	4865
	Complete submission text file	0001193125-12-067417.txt		15392605

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	teva-20111231.xml	EX-101.INS	2475672
8	XBRL TAXONOMY EXTENSION SCHEMA	teva-20111231.xsd	EX-101.SCH	164047
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20111231_cal.xml	EX-101.CAL	134732
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20111231_def.xml	EX-101.DEF	472008
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20111231_lab.xml	EX-101.LAB	1037585
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20111231_pre.xml	EX-101.PRE	888816

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)